1. Home
  2. ROIV vs INGR Comparison

ROIV vs INGR Comparison

Compare ROIV & INGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • INGR
  • Stock Information
  • Founded
  • ROIV 2014
  • INGR 1906
  • Country
  • ROIV United Kingdom
  • INGR United States
  • Employees
  • ROIV N/A
  • INGR N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • INGR Packaged Foods
  • Sector
  • ROIV Health Care
  • INGR Consumer Staples
  • Exchange
  • ROIV Nasdaq
  • INGR Nasdaq
  • Market Cap
  • ROIV 8.4B
  • INGR 8.4B
  • IPO Year
  • ROIV N/A
  • INGR 1997
  • Fundamental
  • Price
  • ROIV $10.67
  • INGR $135.84
  • Analyst Decision
  • ROIV Buy
  • INGR Hold
  • Analyst Count
  • ROIV 4
  • INGR 5
  • Target Price
  • ROIV $17.50
  • INGR $150.20
  • AVG Volume (30 Days)
  • ROIV 5.9M
  • INGR 462.6K
  • Earning Date
  • ROIV 05-29-2025
  • INGR 05-06-2025
  • Dividend Yield
  • ROIV N/A
  • INGR 2.37%
  • EPS Growth
  • ROIV N/A
  • INGR N/A
  • EPS
  • ROIV N/A
  • INGR 9.47
  • Revenue
  • ROIV $122,585,000.00
  • INGR $7,361,000,000.00
  • Revenue This Year
  • ROIV N/A
  • INGR $3.18
  • Revenue Next Year
  • ROIV N/A
  • INGR $2.60
  • P/E Ratio
  • ROIV N/A
  • INGR $14.29
  • Revenue Growth
  • ROIV 140.04
  • INGR N/A
  • 52 Week Low
  • ROIV $8.73
  • INGR $111.54
  • 52 Week High
  • ROIV $13.06
  • INGR $155.44
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 47.82
  • INGR 57.79
  • Support Level
  • ROIV $10.58
  • INGR $134.38
  • Resistance Level
  • ROIV $11.77
  • INGR $138.74
  • Average True Range (ATR)
  • ROIV 0.34
  • INGR 2.52
  • MACD
  • ROIV -0.07
  • INGR 0.54
  • Stochastic Oscillator
  • ROIV 7.56
  • INGR 63.48

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About INGR Ingredion Incorporated

Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.

Share on Social Networks: